13F filer · CIK 1457320 ↗
Exchange Traded Concepts, LLC
You are looking at Q2 2020. See the latest, Q3 2026 →
Reported value
$602.9M
+226% on the quarter before
Positions
754
343 new · 138 sold out
Top 10
16.8%
of the value
Est. gain
+$24.5M
on stocks held all quarter
Est. return
+21.6%
on those stocks since Q1 2020
Positions as of Jun 30, 2020, from Exchange Traded Concepts, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 33% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2020. Striped tiles are options.
Largest buys
Since Q1 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Target Corp~$10.7MAdded · 0.0% → 1.8%+89,468 shares
- Eli Lilly~$10.5MAdded · 0.2% → 1.8%+63,951 shares
- Walmart Inc~$9.7MAdded · 0.2% → 1.7%+80,904 shares
- Ishares Tr~$8.8MNew · 0.0% → 1.5%+79,306 shares
- Biogen Inc~$8.1MAdded · 0.8% → 1.6%+30,295 shares
- Pfizer Inc~$7.9MNew · 0.0% → 1.3%+240,396 shares
- Gan Ltd~$7.7MNew · 0.0% → 1.3%+300,570 shares
- Intel~$7.4MAdded · 0.2% → 1.3%+123,751 shares
- Colgate Palmolive Co~$7.2MAdded · 0.9% → 1.5%+98,749 shares
- Procter And Gamble Co~$7.2MAdded · 0.4% → 1.3%+60,069 shares
Largest sells
Since Q1 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ebay Inc.~$2.6MCut · 0.9% → 0.1%−49,682 shares
- Vanguard World Fds~$2.5MCut · 1.3% → 0.1%−9,005 shares
- Bristol-Myers Squibb Co~$2.2MCut · 1.2% → 0.0%−37,482 shares
- Dollar Gen Corp New~$2.2MCut · 1.1% → 0.1%−11,544 shares
- Monster Beverage Corp New~$2.2MCut · 1.0% → 0.0%−31,524 shares
- Booking Holdings Inc~$2.0MCut · 0.9% → 0.0%−1,266 shares
- Crown Castle Intl Corp New~$1.9MCut · 0.8% → 0.0%−10,718 shares
- SPDR S&P 500 ETF Tr~$1.9MCut · 8.6% → 2.8%−6,250 shares
- Allergan Plc~$1.8MSold out · 1.0% → 0.0%−10,319 shares
- Keysight~$1.7MCut · 0.8% → 0.0%−16,722 shares
Holdings
As of Jun 30, 2020. Changes are in shares against Mar 31, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrTR UNIT · shares −10% · price +19.6% | 2.8% | $17.1M | +$2.8M | ||||||||
| Eli LillyCOM · shares +1,930% · price +18.3% | 1.8% | $11.0M | +$84,114 | ||||||||
| Target CorpCOM · shares +14,407% · price +28.4% | 1.8% | $10.8M | +$16,474 | ||||||||
| Walmart IncCOM · shares +2,009% · price +5.3% | 1.7% | $10.2M | +$24,466 | ||||||||
| Biogen IncCOM · shares +627% · price −15.4% | 1.6% | $9.4M | −$236,230 | ||||||||
| Colgate Palmolive CoCOM · shares +397% · price +10.4% | 1.5% | $9.1M | +$171,539 | ||||||||
| Ishares TrSHORT TREAS BD · shares New | 1.5% | $8.8M | — | ||||||||
| Costco Whsl Corp NewCOM · shares +442% · price +6.3% | 1.4% | $8.7M | +$95,004 | ||||||||
| AmazonCOM · shares +427% · price +41.5% | 1.4% | $8.6M | +$480,065 | ||||||||
| Procter And Gamble CoCOM · shares +1,013% · price +8.7% | 1.3% | $7.9M | +$56,679 | ||||||||
| Pfizer IncCOM · shares New | 1.3% | $7.9M | — | ||||||||
| IntelCOM · shares +1,641% · price +10.6% | 1.3% | $7.9M | +$43,110 | ||||||||
| Gan LtdORD SHS · shares New | 1.3% | $7.7M | — | ||||||||
| Charter Communications Inc NCL A · shares +1,073% · price +16.8% | 1.2% | $7.3M | +$89,738 | ||||||||
| Walgreens Boots Alliance IncCOM · shares +2,735% · price −7.3% | 1.2% | $7.2M | −$19,847 | ||||||||
| Us Bancorp DelCOM NEW · shares New | 1.2% | $7.0M | — | ||||||||
| Metlife IncCOM · shares New | 1.2% | $6.9M | — | ||||||||
| Verizon Communications IncCOM · shares +309% · price +2.6% | 1.1% | $6.9M | +$43,335 | ||||||||
| Gilead Sciences IncCOM · shares +225% · price +2.9% | 1.1% | $6.8M | +$59,397 | ||||||||
| Wells Fargo Co NewCOM · shares +269,649% · price −17.2% | 1.1% | $6.7M | −$516.96 | ||||||||
| Philip Morris Intl IncCOM · shares +7,565% · price −4.2% | 1.1% | $6.6M | −$3,750 | ||||||||
| Johnson & JohnsonCOM · shares +549% · price +7.2% | 0.98% | $5.9M | +$61,043 | ||||||||
| QualcommCOM · shares +948% · price +34.8% | 0.91% | $5.5M | +$135,899 | ||||||||
| Draftkings IncCOM CL A · shares New | 0.82% | $4.9M | — | ||||||||
| AppleCOM · shares +110% · price +43.5% | 0.80% | $4.8M | +$698,721 | ||||||||
| Total · 754 positions | 100% | $602.9M | +$24.5M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2020 to Q2 2020: 406 stocks held throughout, up $24.5M (+21.6%).
- SPDR S&P 500 ETF Tr+$2.8M+20%
- Apple+$698,721+43%
- Vereit Inc+$649,656+31%
- Sea+$610,703+142%
- Store Cap Corp+$576,000+31%
- Southwest Airls Co−$33,833−4%
- Brookfield Asset Mgmt Inc−$115,419−26%
- Safehold Inc−$160,660−9%
- Biogen Inc−$236,230−15%
- Edwards Lifesciences Corp−$381,824−63%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 28, 2026 | $25.28B+16% | SEC ↗ |
| Q2 2026 | Aug 11, 2026 (amended) | $21.88B+55% | SEC ↗ |
| Q1 2026 | Apr 15, 2026 | $14.12B+7% | SEC ↗ |
| Q4 2025 | Jan 14, 2026 | $13.14B+12% | SEC ↗ |
| Q3 2025 | Oct 14, 2025 | $11.76B+44% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $8.18B+40% | SEC ↗ |
| Q1 2025 | Apr 17, 2025 | $5.84B+16% | SEC ↗ |
| Q4 2024 | Jan 21, 2025 | $5.03B+18% | SEC ↗ |
| Q3 2024 | Oct 10, 2024 | $4.28B+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.96B+2% | SEC ↗ |
| Q1 2024 | Apr 15, 2024 | $3.88B+4% | SEC ↗ |
| Q4 2023 | Jan 5, 2024 | $3.74B+6% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $3.53B−13% | SEC ↗ |
| Q2 2023 | Jul 20, 2023 | $4.06B+11% | SEC ↗ |
| Q1 2023 | Apr 12, 2023 | $3.65B+5% | SEC ↗ |
| Q4 2022 | Jan 27, 2023 (amended) | $3.49B+14% | SEC ↗ |
| Q3 2022 | Oct 7, 2022 | $3.06B−11% | SEC ↗ |
| Q2 2022 | Jul 20, 2022 | $3.44B−31% | SEC ↗ |
| Q1 2022 | Apr 26, 2022 | $4.98B−3% | SEC ↗ |
| Q4 2021 | Jan 13, 2022 | $5.16B+32% | SEC ↗ |
| Q3 2021 | Oct 18, 2021 | $3.92B+24% | SEC ↗ |
| Q2 2021 | Jul 30, 2021 | $3.16B+18% | SEC ↗ |
| Q1 2021 | Apr 20, 2021 | $2.67B+24% | SEC ↗ |
| Q4 2020 | Jan 19, 2021 | $2.15B+22% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $1.77B+193% | SEC ↗ |
| Q2 2020 | Jul 15, 2020 | $602.9M+226% | SEC ↗ |
| Q1 2020 | Apr 14, 2020 | $184.9M−61% | SEC ↗ |
| Q4 2019 | Jan 22, 2020 | $478.5M | SEC ↗ |